Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Migada, Ltd. — Predicate Candidate Screening
15 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
69 daysmedian FDA review time
146 days90th percentile
15clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K943095 | IV TRANSFER SPIKE | Migada, Ltd. | 1994-09-30 | 94 | 0 |
| K933929 | LAB-SITE(R) SAFETY CANNULA | Migada, Ltd. | 1993-12-07 | 119 | 0 |
| K902881 | LAB-SITE SAFETY NEEDLE | Migada, Ltd. | 1990-09-26 | 86 | 0 |
| K870016 | ARTERIAL BLOOD GASSING MONITORING SYSTEM (ABG) | Migada, Ltd. | 1987-05-28 | 146 | 0 |
| K864453 | EMERGENCY & MILITARY INFUSION SYSTEM | Migada, Ltd. | 1987-01-20 | 69 | 0 |
| K863304 | PRESELECTED FLOW RATE I.V. SET | Migada, Ltd. | 1986-12-09 | 106 | 0 |
| K860952 | I.V. SET WITH AND WITHOUT AIR VENT | Migada, Ltd. | 1986-08-27 | 167 | 0 |
| K861275 | HIGH FLOW I.V. SET | Migada, Ltd. | 1986-06-02 | 56 | 0 |
| K860595 | TRANSFER SET | Migada, Ltd. | 1986-04-07 | 47 | 0 |
| K854365 | IV SETS WITH NO PHTHALATE PLASTICIZER COMPONENTS | Migada, Ltd. | 1986-03-24 | 146 | 0 |
| K860605 | FILTER SET 1) 1.2 MIC FILTER 2) 3.0 MIC FILTER | Migada, Ltd. | 1986-03-24 | 33 | 0 |
| K860201 | PARENTERAL ADMINISTRATION SET | Migada, Ltd. | 1986-02-04 | 13 | 0 |
| K853385 | I.A.S.S., IV SET W/AIR VENT & I.A.P.S. W/O AIRVENT | Migada, Ltd. | 1985-08-23 | 11 | 0 |
| K853386 | MULTISET 40 | Migada, Ltd. | 1985-08-22 | 10 | 0 |
| K853387 | ET - EXTENSION SETS | Migada, Ltd. | 1985-08-22 | 10 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda